A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes
Stadler, M; Germing, U; Kliche, K-O; Josten, K M; Kuse, R; Hofmann, W-K; Schrezenmeier, H; Novotny, J; Anders, O; Eimermacher, H
- 作者Stadler, M; Germing, U; Kliche, K-O; Josten, K M; Kuse, R; Hofmann, W-K; Schrezenmeier, H; Novotny, J; Anders, O; Eimermacher, H
- 卷第18卷
- 期第3期
- 印刷ISSN0887-6924
- 文件大小131.40KB
- 发表时间2004
- DOI10.1038/sj.leu.2403239
- 页码460-465